GoHealth Inc. (NASDAQ:GOCO) saw a downside of -1.71% to close Monday at $5.18 after subtracting -$0.09 on the day. The 5-day average trading volume is 2,348,540 shares of the company’s common stock. It has gained $5.44 in the past week. An average of 3,016,140 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,642,448.
GOCO’s 1-month performance is -7.83% or -$0.44 on its low of $4.72 reached on 10/05/21. The company’s shares have touched a 52-week low of $4.00 and high of $16.37, with the stock’s rally to the 52-week high happening on 01/08/21. YTD, GOCO has lost -62.08% or -$8.48. However, the current price is down -68.35%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Jun 16, 118 days have gone by since the last insider trading activity for GoHealth Inc. (GOCO). Cruz Shane E. (Chief Operating Officer) most recently sold 62,500 shares at $11.24 per share on Jun 16. This transaction cost the insider $702,538. Chief Operating Officer, Cruz Shane E., sold 62,500 shares at a price of $11.61 on May 18. Then, on Apr 26, Chief Operating Officer Cruz Shane E. sold 75,000 shares at a price of $12.17 per share. This transaction amounted to $912,848.
GoHealth Inc. (GOCO) has a trailing price-to-earnings (P/E) ratio of 13.00 for the broader industry and 12.78 for the sector. The company’s PE ratio for the last five years has touched a high of 926.72 and a low of 528.29. GOCO stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.65 while the price-to-book (PB) in the most recent quarter is 3.52.
GoHealth Inc.’s quick ratio for the period ended June 29 was 2.60, with the current ratio over the same period at 2.60 meaning that GOCO stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.88, while the total debt to equity was 0.89. In terms of profitability, the gross margin trailing 12 months is 79.60%. while for the period ending June 29; GoHealth Inc.’s operating margin was -8.50%. The firm’s gross profit as reported stood at $678.15 million against revenue of $877.35 million.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected GOCO to announce -$0.04 per share in earnings in its latest quarter, but it posted -$0.12, representing a -200.00% surprise. EBITDA for the quarter stood at more than $7.37 million. GOCO stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 745.83 million, with total debt at $419.18 million. Shareholders hold equity totaling $320.83 million
Let’s look briefly at GoHealth Inc. (GOCO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 49.97% to suggest the stock is trending Neutral, with historical volatility in this time period at 64.63%.
The stock’s 5-day moving average is $5.15, reflecting a +9.51% or $0.45 change from its current price. GOCO is currently trading -10.07% above its 20-day SMA, -56.10% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -41.14% and -62.79% respectively.
Stochastic %K and %D was 63.65% and 55.78% and the average true range (ATR) pointed at 0.31. The RSI (14) points at 46.38%, while the 14-day stochastic is at 56.02% with the period’s ATR at 0.33. The stock’s 9-day MACD Oscillator is pointing at 0.18 and 0.12 on the 14-day charts.
In the most recent analyst report for GoHealth Inc. (NASDAQ: GOCO), Raymond James downgraded it to a Mkt perform rating. They previously had an Outperform rating on the stock. Analysts offering their rating for GOCO stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate GOCO as a “sell,”, while 4 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 5 have offered a “buy” rating.
What is GOCO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $7.00 and a high of $17.00, with their median price target at $11.50. Looking at these predictions, the average price target given by analysts is for GoHealth Inc. (GOCO) stock is $11.75.